Withdrawal: Makena

Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.

Recent Announcements

Medical device correction: FreeStyle Libre 3 (Abbott – December)

Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.
Dec. 2025Pharmacy Updates

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates